# Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery

> **NCT06222268** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Wayne State University** · enrollment: 280 (estimated)

## Conditions studied

- PTSD
- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Cannabidiol (CBD) only
- **DRUG:** Placebo only
- **DRUG:** Delta-9-tetrahydrocannabinol (THC) only
- **DRUG:** THC:CBD 1:1

## Key facts

- **NCT ID:** NCT06222268
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2031-09
- **Final completion:** 2031-09
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06222268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06222268, "Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06222268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*